SCHEMBL6649724

SCHEMBL6649724

O=CC(Br)c1sccc1Br

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADRA1D P25100 2/20 0.37
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413447 0.78 MAPT (0.32) —
SCHEMBL6882418 0.78 ALOX5 (0.41) ADRA1DPOLB
SCHEMBL7071154 0.72 GSK3B (0.31) —
SCHEMBL28811183 0.71 — —
SCHEMBL13919765 0.69 — —
SCHEMBL27688660 0.65 ADRA1D (0.42) ADRA1DPOLB
SCHEMBL18003233 0.65 — —
SCHEMBL964511 0.64 — —
SCHEMBL1474968 0.64 ADRA1D (0.45) ADRA1DPOLB
SCHEMBL19219824 0.64 ADRA1D (0.38) ADRA1DPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406632-A2 SUBSTITUTED 3-ARYL-5-ARYL- 1,2,4]-OXADIAZOLES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2004-04-14 — — EP disclosed
WO-2002100826-A2 SUBSTITUTED 3-ARYL-5-ARYL-[1,2,4]-OXADIAZOLES AND ANALOGS CYTOVIA, INC. (US) 2002-12-19 — — WO disclosed
Send feedback